Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations.
Saved in:
| Title: | Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations. |
|---|---|
| Authors: | Yang Y; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Pharmacy, Guangdong Sanjiu Brain Hospital, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Wang Z; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Xiao T; Department of Clinical Research, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China; and., Ni X; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Song E; Department of Pharmacy, Guangdong North Third People's Hospital, Shaoguan, China., Dai L; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Pharmacy, Guangdong Sanjiu Brain Hospital, Guangzhou, China., Chen Y; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Lu H; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Shang D; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Wen Y; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou. |
| Source: | Therapeutic drug monitoring [Ther Drug Monit] 2024 Dec 12; Vol. 47 (4), pp. 545-550. Date of Electronic Publication: 2024 Dec 12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39671209 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Pharmacy, Guangdong Sanjiu Brain Hospital, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.<br /><searchLink fieldCode="AU" term="%22Xiao+T%22">Xiao T</searchLink>; Department of Clinical Research, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China; and.<br /><searchLink fieldCode="AU" term="%22Ni+X%22">Ni X</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.<br /><searchLink fieldCode="AU" term="%22Song+E%22">Song E</searchLink>; Department of Pharmacy, Guangdong North Third People's Hospital, Shaoguan, China.<br /><searchLink fieldCode="AU" term="%22Dai+L%22">Dai L</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Pharmacy, Guangdong Sanjiu Brain Hospital, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.<br /><searchLink fieldCode="AU" term="%22Lu+H%22">Lu H</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.<br /><searchLink fieldCode="AU" term="%22Shang+D%22">Shang D</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.<br /><searchLink fieldCode="AU" term="%22Wen+Y%22">Wen Y</searchLink>; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227909660%22">Therapeutic drug monitoring</searchLink> [Ther Drug Monit] 2024 Dec 12; Vol. 47 (4), pp. 545-550. <i>Date of Electronic Publication: </i>2024 Dec 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7909660 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-3694 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201634356%22">01634356 </searchLink><i>NLM ISO Abbreviation: </i>Ther Drug Monit <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39671209 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/FTD.0000000000001298 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 545 Titles: – TitleFull: Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang Y – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Xiao T – PersonEntity: Name: NameFull: Ni X – PersonEntity: Name: NameFull: Song E – PersonEntity: Name: NameFull: Dai L – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Lu H – PersonEntity: Name: NameFull: Shang D – PersonEntity: Name: NameFull: Wen Y IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 12 Text: 2024 Dec 12 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1536-3694 Numbering: – Type: volume Value: 47 – Type: issue Value: 4 Titles: – TitleFull: Therapeutic drug monitoring Type: main |
| ResultId | 1 |
